Pentoxifylline (State of Florida DOH Central Pharmacy)
Welcome to the PulseAid listing for the Pentoxifylline drug offered from State of Florida DOH Central Pharmacy. This Blood Viscosity Reducer [EPC],Hematologic Activity Alteration [PE] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | State of Florida DOH Central Pharmacy |
NON-PROPRIETARY NAME: | Pentoxifylline |
SUBSTANCE NAME: | PENTOXIFYLLINE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Blood Viscosity Reducer [EPC],Hematologic Activity Alteration [PE] |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET, FILM COATED, EXTENDED RELEASE |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2009-07-01 |
END MARKETING DATE: | 0000-00-00 |
Pentoxifylline HUMAN PRESCRIPTION DRUG Details:
Item Description | Pentoxifylline from State of Florida DOH Central Pharmacy |
LABELER NAME: | State of Florida DOH Central Pharmacy |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 400(mg/1) |
START MARKETING DATE: | 2009-07-01 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 53808-0516_23daa058-b3fc-4518-89e4-7da98cd2f0ec |
PRODUCT NDC: | 53808-0516 |
APPLICATION NUMBER: | ANDA075191 |
Other PENTOXIFYLLINE Pharmaceutical Manufacturers / Labelers: